Pediatric Primary Care Case Studies (147 page)

wheezing,
251
–266

for functional/mental health problems,
73
–230

abuse situations,
193
–206

ADHD,
175
–192

breastfeeding/slow weight gain,
103
–114

constipation (school-age children),
115
–132

depression (adolescents),
207
–220

LGBT issues (adolescents),
221
–231

overweight (preschoolers),
85
–102

PPEs (adolescents),
133
–163

sleep patterns (infants),
163
–175

well-child care (infants),
75
–84

Healthy People 2010 goals,
104

HEAT (Healthy Eating and Activity Together) Initiative,
96

hemoglobin/hematocrit counts.
See
H&H (hemoglobin/hematocrit) counts

hemolytic uremic syndrome.
See
HUS (hemolytic uremic syndrome)

hepatitis

autoimmune,
472
–473

hepatitis B immunizations,
503
–504

H&H (hemoglobin/hematocrit) counts,
428

high blood sugar/overweight,
267
–290

case presentation for,
267
–269,
275
–276,
283
–284

diagnosis of,
268
–276

ADA criteria,
270
–271,
271
t

blood glucose diaries,
268
t

diabetes,
269
–284

differential,
275
–276,
275
t

history-taking,
267
–268

obesity,
271
–284

physical examination,
268
–269

prediabetes,
270
–271,
271
t

epidemiology/etiology of,
269
–275

Bogalusa Heart Study,
272
–273

DCCT,
274
–275

ERIC,
274

pathophysiology,
269
–271

SEARCH for Diabetes in Youth Study,
272
–274

TODAY Study,
277

TRIGR study,
273
–274

type 1 diabetes,
273
–275,
275
t

type 2 diabetes,
269
–271,
275
t

fundamental contexts of,
267
–268,
284

management of,
270
t,
276
–284

CDC Healthy Weight recommendations,
278
–279

comorbidities,
280
–281

depression,
281

developmental factors,
279
–280

DHHS recommendations,
279

dyslipidemia,
280
–281

education plans,
282
–284

follow-up visits,
284

hypertension,
280

medications,
277
–278

microvascular complications,
281

NDEP,
270
t

nutritional changes,
278
–279

physical activity changes,
279

renal disease,
281

sociocutural factors,
281
–282

therapy goals,
277

treatment options,
277
–278

objectives for,
267

resources for,
270
t,
285
–290

hip dysplasia,
484
–487

HIV (human immunodeficiency virus),
235
–237

hormonal agents,
472
–473

HPV (human papilloma virus) vaccine,
438
–439

human immunodeficiency virus.
See
HIV (human immunodeficiency virus)

human metapneumovirus,
379
t

human papilloma virus vaccine.
See
HPV (human papilloma virus) vaccine

HUS (hemolytic uremic syndrome),
395
–396

Hylira,
460

hyperactivity.
See
ADHD (attention deficit hyperactivity disorder)

hypnotics,
68

hypothyroidism,
306
–307,
309

I

I PREPARE mnemonic,
298
–299,
299
t

ICD-9 codes, anemia,
313
t

IDA (iron deficiency anemia),
300
–303,
300
t,
308
.
See also
anemia (toddlers)

Identifying and Preventing Overweight in Childhood
,
96

IHS (International Headache Society) classification,
322
–324

IM (infectious mononucleosis),
234
–237

immunizations

AAP recommendations for,
504

HPV vaccine,
438
–439

for late-preterm infants,
503
–504

impetigo,
459

Impruv,
460

inattentive/busy child diagnoses.
See also
ADHD (attention deficit hyperactivity disorder)

case presentation for,
176
,
178
,
180
,
186
,
189
–190

diagnosis of,
176
–181

follow-up visits for,
189
–190

fundamental contexts of,
175
,
191

management of,
182
–190

objectives for,
175

prognosis for,
190

resources for,
191
–192

infant/newborn-specific concerns

breastfeeding/slow weight gain,
103
–114

diagnostic reasoning for,
1
–8

gross motor delays,
11
–26

sleep patterns,
163
–175

well-child care

infants,
75
–84

late-preterm infants,
493
–506

infectious mononucleosis.
See
IM (infectious mononucleosis)

influenza,
379
t

inhaled corticosteroids,
260
.
See also
corticosteroids

insulin,
268
t,
277
–278

International Headache Society classification.
See
IHS (International Headache Society) classification

intrauterine devices,
433

intussusception,
395
–396